Filed: 5/15/2024ACC: 0001931118-24-000007
📋 What this filing means
SUPERSTRING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 37 equity positions with a total reported market value of $151.24M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
37
Positions
$151.24M
Total AUM (reported)
13.38M
Total Shares
Allocation by class
COM$109.90M72.7%
COM NEW$27.12M17.9%
SHS$5.60M3.7%
SPONSORED ADS$4.37M2.9%
COMMON STOCK$2.10M1.4%
SPONSORED ADR$1.93M1.3%
ORDINARY SHARES$215.5K0.1%
Portfolio Concentration
Top 3$43.37M28.7%
4–10$54.11M35.8%
11–25$44.90M29.7%
Rest$8.86M5.9%
Top 3 weight
28.7%
Top 10 weight
64.5%
Voting Authority Distribution
Total shares with voting rights: 13.38M
Sole
Full voting authority
13.38M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole37
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings37
Rows:
CYTOKINETICS INC
SOLEShares278.92K
TypeSH
Market value$19.55M
12.93%
Sole
278.92K
Shared
0.00
None
0.00
NKARTA INC
SOLEShares1.19M
TypeSH
Market value$12.86M
8.50%
Sole
1.19M
Shared
0.00
None
0.00
89BIO INC
SOLEShares941.29K
TypeSH
Market value$10.96M
7.24%
Sole
941.29K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares353.51K
TypeSH
Market value$10.93M
7.23%
Sole
353.51K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares2.07M
TypeSH
Market value$10.28M
6.80%
Sole
2.07M
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares217.07K
TypeSH
Market value$9.53M
6.30%
Sole
217.07K
Shared
0.00
None
0.00
FATE THERAPEUTICS INC
SOLEShares920.48K
TypeSH
Market value$6.76M
4.47%
Sole
920.48K
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares349.68K
TypeSH
Market value$5.78M
3.82%
Sole
349.68K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares531.02K
TypeSH
Market value$5.60M
3.70%
Sole
531.02K
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares120.90K
TypeSH
Market value$5.24M
3.47%
Sole
120.90K
Shared
0.00
None
0.00
MARINUS PHARMACEUTICALS INC
SOLEShares565.55K
TypeSH
Market value$5.11M
3.38%
Sole
565.55K
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares290.80K
TypeSH
Market value$4.96M
3.28%
Sole
290.80K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares288.27K
TypeSH
Market value$4.32M
2.86%
Sole
288.27K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares259.38K
TypeSH
Market value$4.17M
2.76%
Sole
259.38K
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares110.26K
TypeSH
Market value$3.26M
2.16%
Sole
110.26K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares44.87K
TypeSH
Market value$2.98M
1.97%
Sole
44.87K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares36.61K
TypeSH
Market value$2.92M
1.93%
Sole
36.61K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares99.82K
TypeSH
Market value$2.83M
1.87%
Sole
99.82K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares40.12K
TypeSH
Market value$2.45M
1.62%
Sole
40.12K
Shared
0.00
None
0.00
ALLOGENE THERAPEUTICS INC
SOLEShares521.25K
TypeSH
Market value$2.33M
1.54%
Sole
521.25K
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares33.83K
TypeSH
Market value$2.24M
1.48%
Sole
33.83K
Shared
0.00
None
0.00
PYXIS ONCOLOGY INC
SOLEShares493.76K
TypeSH
Market value$2.10M
1.39%
Sole
493.76K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares12.75K
TypeSH
Market value$1.93M
1.27%
Sole
12.75K
Shared
0.00
None
0.00
PEPGEN INC
SOLEShares114.39K
TypeSH
Market value$1.68M
1.11%
Sole
114.39K
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares69.97K
TypeSH
Market value$1.60M
1.06%
Sole
69.97K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CYTOKINETICS INCSOLE | COM NEW | 278.92K | SH | $19.55M 12.93% | 278.92K | 0.00 | 0.00 |
NKARTA INCSOLE | COM | 1.19M | SH | $12.86M 8.50% | 1.19M | 0.00 | 0.00 |
89BIO INCSOLE | COM | 941.29K | SH | $10.96M 7.24% | 941.29K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 353.51K | SH | $10.93M 7.23% | 353.51K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 2.07M | SH | $10.28M 6.80% | 2.07M | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 217.07K | SH | $9.53M 6.30% | 217.07K | 0.00 | 0.00 |
FATE THERAPEUTICS INCSOLE | COM | 920.48K | SH | $6.76M 4.47% | 920.48K | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 349.68K | SH | $5.78M 3.82% | 349.68K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 531.02K | SH | $5.60M 3.70% | 531.02K | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 120.90K | SH | $5.24M 3.47% | 120.90K | 0.00 | 0.00 |
MARINUS PHARMACEUTICALS INCSOLE | COM NEW | 565.55K | SH | $5.11M 3.38% | 565.55K | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 290.80K | SH | $4.96M 3.28% | 290.80K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 288.27K | SH | $4.32M 2.86% | 288.27K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 259.38K | SH | $4.17M 2.76% | 259.38K | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COM | 110.26K | SH | $3.26M 2.16% | 110.26K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 44.87K | SH | $2.98M 1.97% | 44.87K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 36.61K | SH | $2.92M 1.93% | 36.61K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 99.82K | SH | $2.83M 1.87% | 99.82K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 40.12K | SH | $2.45M 1.62% | 40.12K | 0.00 | 0.00 |
ALLOGENE THERAPEUTICS INCSOLE | COM | 521.25K | SH | $2.33M 1.54% | 521.25K | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 33.83K | SH | $2.24M 1.48% | 33.83K | 0.00 | 0.00 |
PYXIS ONCOLOGY INCSOLE | COMMON STOCK | 493.76K | SH | $2.10M 1.39% | 493.76K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 12.75K | SH | $1.93M 1.27% | 12.75K | 0.00 | 0.00 |
PEPGEN INCSOLE | COM | 114.39K | SH | $1.68M 1.11% | 114.39K | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COM | 69.97K | SH | $1.60M 1.06% | 69.97K | 0.00 | 0.00 |
Page 1 of 2